Sinonasal Cancer clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
open to eligible people ages 18 years and up
This phase II/III compares the standard therapy (chemotherapy plus cetuximab) versus adding bevacizumab to standard chemotherapy, versus combination of just bevacizumab and atezolizumab in treating patients with head and neck cancer that has spread…
at UC Irvine
Our lead scientists for Sinonasal Cancer research studies include Shirin Attarian.
Last updated: